openPR Logo

Press Releases from Atrial Fibrillation (1 total)

Atrial Fibrillation - Global Drug Forecast And Market Analysis To 2025

Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregular and often abnormally fast heart rate. Various therapeutic options are available to treat patients with AF, and most patients will receive some form of antithrombotic therapy, a heart rate control agent, and potentially an antiarrhythmic drug for rhythm control. All sectors of the AF market have historically been saturated with generics, with the

Go To Page:   1 2 3 4 5 6 7 8 9 10